Cite
SCN5A mutation type and topology are associated with the risk of ventricular arrhythmia by sodium channel blockers.
MLA
Amin, Ahmad S., et al. “SCN5A Mutation Type and Topology Are Associated with the Risk of Ventricular Arrhythmia by Sodium Channel Blockers.” International Journal of Cardiology, vol. 266, Sept. 2018, pp. 128–32. EBSCOhost, https://doi.org/10.1016/j.ijcard.2017.09.010.
APA
Amin, A. S., Reckman, Y. J., Arbelo, E., Spanjaart, A. M., Postema, P. G., Tadros, R., Tanck, M. W., Van den Berg, M. P., Wilde, A. A. M., & Tan, H. L. (2018). SCN5A mutation type and topology are associated with the risk of ventricular arrhythmia by sodium channel blockers. International Journal of Cardiology, 266, 128–132. https://doi.org/10.1016/j.ijcard.2017.09.010
Chicago
Amin, Ahmad S., Yolan J. Reckman, Elena Arbelo, Anne M. Spanjaart, Pieter G. Postema, Rafik Tadros, Michael W. Tanck, Maarten P. Van den Berg, Arthur A.M. Wilde, and Hanno L. Tan. 2018. “SCN5A Mutation Type and Topology Are Associated with the Risk of Ventricular Arrhythmia by Sodium Channel Blockers.” International Journal of Cardiology 266 (September): 128–32. doi:10.1016/j.ijcard.2017.09.010.